Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

AXA launches new product for SMEs with global teams

AXA Global Healthcare, offering global health insurance to expats, businesses, students and more, has announced the launch of Global Health Adapt, a new product designed to meet the needs of small and medium-sized enterprises (SMEs) with a globally based workforce. 
November 14, 2024

FREE BLOG With growing investments, 2025 looks promising for the femtech sector

October marked Breast Cancer Awareness Month, focused on awareness, early detection, and research funding. Women’s health, historically neglected, is now a key focus for startups and private equity firms. Female health providers are leveraging telemedicine and AI to address market needs from puberty to postmenopause.
November 8, 2024

German states resisting hospital reform, Health Ministry threatens to withhold financing

Germany’s federal states are attempting to amend the Hospital Care Improvement Act (Krankenhausversorgungsverbesserungsgesetz, KHVVG), which was approved by Germany’s Bundestag in October but still has to be voted on by the upper house. The federal health ministry is threatening to withhold finance for the states if they block the reform.
November 8, 2024

CUF buys primary care chain miMed 

CUF, Portugal’s largest for-profit hospital group, has bought miMed, a chain of 13 primary care walk-in clinics in Lisbon. The clinics will begin operating under CUF’s brand in Q1 2025.
November 8, 2024

What do the struggles of Australia’s private hospitals mean for private equity investors?

Private hospitals in Australia are facing a severe financial crisis, as highlighted by a recent Department of Health review. While the financial struggles of these hospitals are not new, this is the first time the government has conducted a review and officially acknowledged the issue. The review found that private hospital profit margins have nearly halved over five years as costs outpaced revenue, with “imminent closures” likely without urgent government intervention.
November 8, 2024

Exploring the GCC’s prospective $11 billion GLP-1 RA market — ‘a unique opportunity to lead in this space’

Demand for GLP-1 receptor agonists (the class of drugs used to treat obesity and diabetes) has been growing rapidly, opening up more and more opportunities in the market, such as ‘holistic’ online prescription services. We’ve seen both the positives and negatives of the use of GLP-1 RAs in the US and Europe, from transforming people’s health for the better to misuse and inappropriate supply. But what do we know about the market in the Middle East?
November 8, 2024

Allianz rolls out its Elevate plan across Europe

Allianz Partners, a leader in B2B2C insurance and assistance, offering global solutions across international health and life, travel insurance, mobility and assistance, has announced the launch of “first to market” Elevate, its healthcare top-up plan.  Sold through the Allianz Partners health brand, Elevate was previously known as the EU Top-up Plan available only in Germany. It is now available for employees across the European Union (EU) and European Economic Area (EEA). 
November 6, 2024
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us